Clinical Trials Logo

Filter by:
NCT ID: NCT06112457 Not yet recruiting - Clinical trials for Anxiety Depression Disorder

Anxiety and Depression Among Gendarmes Posted to French Guiana

TAD-GENDGF
Start date: November 2023
Phase:
Study type: Observational [Patient Registry]

This is a mixed-method, single-center study involving two concurrent phases: a quantitative phase with an anonymous self-administered questionnaires, and a qualitative phase with individual contextual interviews and a focus group. The hypothesis underlying this study is that isolated postings are a risk factor for anxiety-depressive disorders. The aim of this study is to provide new information to help propose targeted prevention and health promotion measures.

NCT ID: NCT06095076 Recruiting - Dysbiosis Clinical Trials

Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)

ICMc
Start date: June 2, 2023
Phase:
Study type: Observational

Intensive Care Unit (ICU) patients are exposed to catheter-related infections with an important morbidity. Catheter colonization is constant but infection is not. Cutaneous dysbiosis could be the missing link. Our study aims to evaluate the evolution of cutaneous microbiota in ICU patients with a central venous catheter in place, through metagenomics. Our main objective is to evaluate the evolution of alpha-diversity, quantified by intra-patient variation of Shannon diversity index (a diversity index used in bacterial metagenomics).

NCT ID: NCT06065553 Recruiting - Clinical trials for Substance Use Disorders

Prevalence of Psychiatric and Substance Abuse Disorders Among People in Precarious Situations in Cayenne

EPICEA
Start date: June 9, 2023
Phase:
Study type: Observational

This is an observational, descriptive, cross-sectional, single-center study. The main objective of the study is to estimate the prevalence of the main psychiatric disorders and substance abuse disorders among people living in precarious, excluded and/or wandering on Cayenne and its surroundings

NCT ID: NCT05788731 Completed - Chronic Disease Clinical Trials

Become of Patients From the Permanent Access to Care (PASS) in Cayenne, French Guyana, Suffering From a Chronic Disease (High Blood Pressure - Diabetes) in the Common Law Schemes

PASSyDroit
Start date: January 18, 2023
Phase:
Study type: Observational

It is an observational research, conducted at the Cayenne hospital about the future of hypertensive and/or diabetic patients after their follow-up at the Permanent Access to care (PASS). The PASS is a medico-social structure that allows access to medical monitoring and support towards common law. The main objective of the study is to evaluate the use of the common law system by these patients. Then the goal is to study the relationship between integration into the system and socio-demographic, medical characteristics, and understanding of health monitoring. Data will be collected by guided telephone interviews and the review of medical records.

NCT ID: NCT05653128 Not yet recruiting - Pregnancy Related Clinical Trials

Food and Nutrition Insecurity During Pregnancy in French Guiana

NutriPouTiMoun
Start date: January 2023
Phase:
Study type: Observational

This is a cross-sectional study of a representative sample of women who gave birth in the 3 maternity hospitals of French Guiana. The main objective is to estimate the prevalence of food insecurity among pregnant women admitted for delivery in one of the maternity hospitals of French Guiana. A biological assay of deficiencies and toxic metals as well as the completion of a questionnaire will answer the research question

NCT ID: NCT05354934 Recruiting - Clinical trials for Human Immunodeficiency Virus

Study of Entry and Continuation in Care for People Living With HIV in French Guiana

EMVIH
Start date: March 23, 2022
Phase:
Study type: Observational

Research Involving the Non-Interventional Human Subject (RIPH category 3). Non-interventional, cross-sectional, multicentre, descriptive and analytical epidemiological study. A cross-sectional, pseudo-anonymous questionnaire focusing on entry and retention in care will be administered to a sample of PLHIV presenting for consultation in one of the GHT hospitals over a 12-month period. A sample of 300 PHAs is envisaged to have sufficient power to highlight the main factors associated with periods of loss of sight. Main objective: - To identify factors associated with loss of sight for more than 12 months among people living with HIV in Guyana Secondary objectives: - To identify factors associated with a delay in the introduction of ARVs among PLHIV in Guyana - To describe the perception of the quality of the announcement of the diagnosis of HIV - To describe the difficulties encountered by PLHIV during their hospital follow-up in French Guyana - To assess the perceived stigma associated with HIV and its consequences in daily life

NCT ID: NCT05174234 Recruiting - HIV Seropositivity Clinical Trials

Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana

ParcoursHaiti
Start date: November 4, 2021
Phase:
Study type: Observational

French Guiana, a French territory located in South America, faces several social challenges including financial insecurity, unemployment and significant immigration. The degraded living conditions of migrants arriving in the territory are likely to put them in a situation of sexual vulnerability that could increase their risk of acquiring HIV (human immunodeficiency virus). This study proposes to conduct a survey of a group of people living with HIV in French Guiana who were born in Haiti and a group of Haitian people who are not HIV positive. With the help of interviewers who speak Haitian Creole, it will allow us to better understand the life paths of people from Haiti and their periods of vulnerability. Investigators will also focus on the use of testing and retention in care for those living with HIV. The results of this work will allow for the mobilization of resources and better adjustment of social support, prevention and care interventions implemented in French Guiana for migrant populations and/or those in precarious situations.

NCT ID: NCT05031091 Recruiting - Hansen's Disease Clinical Trials

Epidemiology of Leprosy in French Guiana

EPI-LEPR
Start date: January 7, 2020
Phase:
Study type: Observational

The main objective of the present study is the genotyping of M. leprae strains found in leprosy patients in French Guiana. The secondary objectives are to investigate the presence of M. lepromatosis in these patients, the molecular research of M. leprae resistance to anti-leprosy antibiotics, the study of risk factors for leprosy in humans in Guyana and in particular direct or indirect contact with armadillos, as well as the determination of phylogenetic links between the M. leprae strains found in French Guiana, and with the regional and world reference strains Epidemiology of leprosy in French Guiana.

NCT ID: NCT05025891 Recruiting - HIV Clinical Trials

ISe-santé, a Study Evaluating a Model for Implementing E-health in the Management of HIV Patients

Start date: February 4, 2021
Phase: N/A
Study type: Interventional

It is a randomized, controlled, open-label, parallel group study of 3 arms, among patients followed for chronic HIV infection at Cayenne hospital. The main objective of the study is to evaluate the effectiveness of follow-up of these patients by teleconsultation associated or not with health mediation.

NCT ID: NCT05024461 Active, not recruiting - Covid19 Clinical Trials

Comparison of Detection of SARS-CoV2 (COVID-19) Between Nasopharyngeal Swab Specimens and Those Obtained by Salivary Sputum

COVISAL
Start date: August 10, 2020
Phase: N/A
Study type: Interventional

Multicenter observational study of diagnostic test validation (Research Involving the Human Person, type 3) In addition to the diagnosis by the reference method (nasopharyngeal swab), the patient will be asked to provide a saliva sample via a salivary spit. The clinical circumstances of the diagnosis, the age of the patient, the associated terrain (diabetes, immunodepression, pregnancy) will be noted. The nasopharyngeal and saliva samples will be analyzed in Cayenne and the remaining samples will be frozen and stored at the CRB before being sent to the University Hospital of Caen for analysis and concordance verification. The expected benefits are: Possibility of repeating tests in the same person more easily due to the absence of pain and thus reduce the barriers to diagnosis and screening. Possibility of self-sampling, which could simply be sent to the laboratory, which would relieve the diagnostic sites that mobilize staff and require a fairly heavy organization. Avoid long waiting lines that can be an obstacle and lead to a renunciation of the diagnosis.